YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains?
Y-mAbs Therapeutics, Inc. (YMAB) shares ended the last trading session 103.3% higher at $8.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.7% loss over the past four weeks.The stock rallied after SERB Pharmaceuticals announced that it would acquire Y-mAbs Therapeutics in an all-cash transaction for an equity value of approximately $412 million. The transaction is expected to be closed by the fourth quarter of ...